{"id":"W2152127926","doi":"10.1186/1756-8722-7-1","title":"Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors","year":2014,"lang":"en","type":"article","venue":"Journal of Hematology & Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":190,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cancer Research UK; National Cancer Institute; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Royal Marsden NHS Foundation Trust","keywords":"Medicine; Docetaxel; Carboplatin; Rash; Internal medicine; Paclitaxel; Erlotinib; Nausea; Febrile neutropenia; Pharmacology; Oncology; Neutropenia; Chemotherapy; Cisplatin; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001359728,0.002191403,0.002226211,0.0004462296,0.0005048809,0.0009185143,0.0009678907,0.001085365,0.004211517],"category_scores_gemma":[0.0007657078,0.0007495461,0.001171794,0.0004509627,0.0009107682,0.0007970876,0.0003592673,0.003844174,0.0009628145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001219015,"about_ca_system_score_gemma":0.002309539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001356454,"about_ca_topic_score_gemma":0.003852565,"domain_scores_codex":[0.9997322,0.0001138988,0.00001296281,0.00005257306,0.00002493576,0.00006340705],"domain_scores_gemma":[0.9994249,0.0000943641,0.000130518,0.00003157318,0.00003378031,0.0002848938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7870821,0.07570429,0.005615251,0.001430931,0.001253528,0.000397084,0.0003214098,0.004408869,0.03091305,0.00034311,0.009298106,0.08323221],"study_design_scores_gemma":[0.7318446,0.2554273,0.005789052,0.00003933498,0.0003318802,0.0002508065,0.0000363214,0.001514901,0.002629168,0.0002143863,0.00189978,0.00002246101],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899604,0.002617602,0.0004550068,0.0007908085,0.0001773205,0.002856567,0.00113639,0.0001340844,0.001871651],"genre_scores_gemma":[0.9860178,0.002407295,0.001718972,0.0009270701,0.0002387607,0.003081091,0.002537237,0.00003833927,0.003033527],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004211517,"threshold_uncertainty_score":0.01408893,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01163486206297069,"score_gpt":0.3165527604870124,"score_spread":0.3049178984240417,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}